Literature DB >> 5039395

Disposition of the antileprosy drug, dapsone, in the mouse.

L Levy, J T Biggs, G R Gordon, J H Peters.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5039395     DOI： 10.3181/00379727-140-36584

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  6 in total

1.  Minimal inhibitory concentration of dapsone for Mycobacterium leprae in rats.

Authors:  J H Peters; G R Gordon; J F Murray; A H Fieldsteel; L Levy
Journal:  Antimicrob Agents Chemother       Date:  1975-11       Impact factor: 5.191

2.  Electrophoretic patterns of serum proteins and immunoglobulin levels in mycobacterial infections--studies in mice infected with mycobacterium leprae and mycobacterium lepraemurium.

Authors:  R G Navalkar; P J Patel; R R Dalvi; M V Kanchana
Journal:  J Natl Med Assoc       Date:  1976-11       Impact factor: 1.798

3.  Activity of derivatives and analogs of dapsone against Mycobacterium leprae.

Authors:  L Levy
Journal:  Antimicrob Agents Chemother       Date:  1978-11       Impact factor: 5.191

4.  Renal and biliary disposition of dapsone in the dog.

Authors:  J T Biggs; A K Uher; L Levy; R D Gordon; J H Peters
Journal:  Antimicrob Agents Chemother       Date:  1975-06       Impact factor: 5.191

5.  Susceptibility of thymectomized and irradiated mice to challenge with several organisms and the effect of dapsone on infection with Mycobacterium leprae.

Authors:  L Levy; H Ng; M J Evans; J L Krahenbuhl
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

6.  Comparative effects of sulfones and rifampin on growth of Mycobacterium lepraemurium in macrophage diffusion chamber cultures.

Authors:  W A Rightsel; M F Sawyers; J H Peters
Journal:  Antimicrob Agents Chemother       Date:  1978-03       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.